In NPC patients, lower FGF5 methylation levels were significantly associated with distant metastasis-free survival (DMFS) but not with overall survival (OS), disease-free survival (DFS), or regional relapse-free survival (RRFS) (Figure 4b–e). The gene discussed is FGF5; the disease is nasopharyngeal carcinoma.